Skip to main content
. 2021 Mar 11;11(11):5346–5364. doi: 10.7150/thno.58385

Figure 3.

Figure 3

HyperMe-DMRs are recurrently hypermethylated. (A) Methylation levels of total hyperMe-DMRs between tumor and normal samples across 21 cancer types. Data are shown as mean ± SD. The top digits signified number of tumor (red) and normal (green) samples analyzed. (B) Methylation levels of total hyperMe-DMRs and the other set of hyperMe-DMRs (i.e., ESC-poised and ESC-active promoter marked hyperMe-DMRs) across tissues, cell types and cancer cell lines. Data are shown as mean ± SD. The top digits signified number of tissues/cells.